INTRODUCTION {#SEC1}
============

Proteins are highly dynamic in nature, and most often, their motions are tightly coupled to functionality. The P-loop NTPase (nucleoside triphosphatase) superfamily ([@B1]) presents numerous examples of proteins that undergo substantial structural transitions as part of their functional cycles, which are related to diverse cellular processes such as transport, signal transduction and translation to mention a few.

Among the NTPases, the GTPase superfamily has been subject to thorough structural studies since the 1980s ([@B2]). These studies established that the identity of the bound guanine nucleotide (i.e. GDP *versus* GTP) gives rise to distinct structural conformations ([@B3]). The guanine-nucleotide binding domains (or G-domains) of all family members display a conserved overall structure and five characteristic consensus sequence motifs with individual roles in GDP/GTP binding ([@B4]). The switching between an active, GTP-bound form and an inactive, GDP-bound form is common to the GTPases and is often regulated by guanine-nucleotide exchange factors (GEFs) and GTPase activating proteins (GAPs). Nucleotide binding and hydrolysis are accompanied by structural changes in two regions, switch I and II, which are thought to be a direct consequence of the presence of either GDP or GTP. A more detailed scheme has however been suggested, in which both structural forms are able to bind both nucleotides ([@B5]). In the case of translation elongation factor Tu (EF-Tu), this was recently highlighted by the finding that EF-Tu·GDP may dissociate from the ribosome in either an open or a closed conformation ([@B6]).

Elongation factor Tu is a GTPase with an essential role in prokaryotic protein synthesis ([@B7]). During the translation elongation cycle, aminoacylated tRNAs (aa-tRNA) are brought to the A site of the mRNA-programmed ribosome in a ternary complex consisting of aa-tRNA, EF-Tu, and GTP. Cognate codon--anticodon interaction induces conformational changes in the ribosome, which stimulates the GTPase activity of EF-Tu. GTP hydrolysis and release of P~i~ result in a conformational rearrangement of EF-Tu leading to release from the ribosome. Reactivation of EF-Tu via guanine-nucleotide exchange is facilitated by elongation factor Ts (EF-Ts).

Numerous structures have been determined of EF-Tu from various organisms covering most states during its catalytic cycle. The initial structure of *E. coli* EF-Tu in complex with GDP showed that EF-Tu consists of three domains organized with a characteristic open cleft in the middle ([@B8]). Subsequently, crystal structures of EF-Tu from *T. aquaticus* and *T. thermophilus* in complex with the GTP analogue guanosine 5′-\[β,γ-imido\]triphosphate (GDPNP) revealed that EF-Tu adopts a more compact or *closed* conformation in the GTP-bound state as opposed to the *open* GDP-bound state ([@B16],[@B17]). The relative orientation of domains II and III is essentially the same in the open and the closed conformation. In contrast, domain I is rotated approximately 90° relative to domains II and III between the GTP- and GDP-bound state and the switch 1 and 2 regions (residues 40--62 and 80--100, respectively, in *E. coli* EF-Tu) are extensively rearranged. A part of the switch 1 region (residues 52--59) changes from a β-hairpin in the EF-Tu·GDP structure to an α-helix in the EF-Tu·GDPNP structure, while the position of an α-helix of the switch 2 region is shifted in the primary sequence. Crystal structures of various ternary complexes show that EF-Tu has a closed conformation, similar to the free EF-Tu·GDPNP structure, when bound to aa-tRNA. The aa-tRNA recognition is mediated by residues from all three domains of EF-Tu (([@B18]) and PDB ID 1OB2). The structure of the ternary complex trapped on the 70S ribosome shows that EF-Tu essentially adopts the same overall closed conformation as in the free ternary complex ([@B21],[@B22]).

Here, we present the first crystal structure of *E. coli* EF-Tu in complex with the non-hydrolysable GTP analogue, GDPNP, at a resolution of 2.50 Å. Remarkably, EF-Tu displays an open conformation similar to the GDP-bound form of the factor. This finding is complemented by a study of the conformational dynamics of EF-Tu in solution. Pairs of fluorescent labels were placed in domains I and III to enable fluorescence resonance energy transfer (FRET) as a measure of interdomain distance to allow distinction between the open and closed forms of EF-Tu and possibly provide evidence for any intermediate or alternate conformations. FRET measurements in the presence of various ligands revealed that EF-Tu in solution exists in a dynamic equilibrium of conformations with similar FRET distributions, irrespective of the nature of the bound guanine nucleotide, even in the ternary complex with aa-tRNA. The GTP-bound form is driven towards the previously described closed conformation only upon binding to the ribosome.

MATERIALS AND METHODS {#SEC2}
=====================

A more detailed description of the applied methods is included in the online [Supplementary Data](#sup1){ref-type="supplementary-material"}.

Purification of *E. coli* EF-Tu for crystallographic studies {#SEC2-1}
------------------------------------------------------------

*E. coli* EF-Tu was purified from Rosetta (DE3) cells by anion chromatography. The protein was eluted with a linear gradient of 50--300 mM KCl. Eluted fractions containing EF-Tu were precipitated in 2.8 M ammonium sulphate. The precipitated protein was further purified by hydrophobic interaction chromatography, with elution by a linear gradient of 1.5--0.75 M ammonium sulphate. The eluted fractions containing EF-Tu were dialyzed and subjected to a second round of anion exchange chromatography.

Nucleotide exchange and crystallization {#SEC2-2}
---------------------------------------

Purified EF-Tu was dialyzed against nucleotide exchange buffer (200 mM ammonium sulphate, 30 mM Tris pH 8.0, 1 mM DTT and 10% glycerol). Subsequent additions brought MgCl~2~ to a final concentration of 1 mM, GDPNP to a molecular ratio of 5:1 with respect to EF-Tu, and alkaline phosphatase to 2 units per mg EF-Tu. The solution was incubated on ice and subsequently clarified by centrifugation. The EF-Tu·GDPNP complex was purified by gel filtration. *E. coli* EF-Tu·GDPNP was concentrated to 8 mg/ml prior to crystallization experiments.

Crystallization trials were carried out at 20°C utilizing the sitting drop vapor diffusion technique. The initial crystallization conditions were established through commercial crystal screens. Subsequently, the crystallization buffer was optimized to 2 M ammonium sulphate, 0.1 M HEPES pH 7.5, 2% (v/v) PEG 400 and 1 mM DTT and single needle crystals were obtained by streak-seeding the drops with serial dilutions of crushed crystals. Single crystals were isolated from the mother liquor and rapidly transferred to cryoprotection buffer (2 M ammonium sulphate, 0.1 M HEPES 7.5 (NaOH) and 20% glycerol) and immediately flash frozen. Data were collected at Maxlab beamline I911-2 (Lund, Sweden).

Data processing and structure determination {#SEC2-3}
-------------------------------------------

Data processing and scaling were performed with the XDS package ([@B23]). Phases were determined by molecular replacement with the Phaser application of Phenix ([@B24]). Search models were prepared from the structure of *E. coli* EF-Tu bound to GDP (PDB ID 1EFC) ([@B10]). The guanine nucleotide and all water molecules were removed and the individual domains were separated and used in combination as search models. Model building was performed in Coot ([@B25]) and the fitted model was refined with Phenix refine ([@B24]). The final model were validated with Procheck ([@B26]) and MolProbity ([@B27]).

Preparation of EF-Tu for solution FRET studies {#SEC2-4}
----------------------------------------------

We sought to detect structural transitions between the open and closed conformations of EF-Tu by introducing a FRET donor (Cy3) and acceptor (Cy5) in each of the domains I and III, at positions which are predicted to move relative to each other during the structural transitions. Sites for introducing Cys residues for labeling with maleimide dyes were selected based on the analysis of the following structures: 70S with stalled *Thermus thermophilus* EF-Tu·GDP·kirromycin·aa-tRNA (PDB codes 1WRN, 1WRO), *E. coli* EF-Tu·GDPNP·kirromycin·aa-tRNA (PDB code: 1OB2) and EF-Tu·GDP (PDB code: 1DG1). Three pairs of amino acid residues, T33/M351, D47/D314 and D165/D314 ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"}), were chosen for labeling, and cysteines were introduced at these positions in a variant of EF-Tu, denoted EF-Tu^AV^, which contains only one native cysteine, as described in the accompanying paper ([@B28]). The resulting mutants, denoted EF-Tu^AV-33/351^, EF-Tu^AV-47/314^ and EF-Tu^AV-165/314^, were expressed, purified, labeled and characterized as described elsewhere ([@B28]).

FRET states of dual-labeled EF-Tu mutants monitored by single-molecule confocal fluorescence burst detection {#SEC2-5}
------------------------------------------------------------------------------------------------------------

Freely diffusing EF-Tu molecules labeled with both fluorescent donor and acceptor (Cy3 and Cy5, respectively) gave rise to bursts of fluorescence on traversing the detection volume of a confocal optical system built around an inverted microscope ([@B29],[@B30]). Low concentrations (50 pM) of the relevant dual-labeled complexes were used to minimize the observation of more than one EF-Tu molecule at any given time. Individual fluorescence photons from freely diffusing complexes of labeled EF-Tu were detected as they passed through the confocal volume using avalanche photodiodes ([@B29],[@B30]), and binned into donor (Cy3) and acceptor (Cy5) channels by a Flex 03-LQ-01 correlator adapter card with a 500 μs integration time. A thresholding scheme applied to the sum of the two channels was used to determine when a molecule was occupying the detection volume. Adjacent time bins which were part of the same event were merged (see Supplement). The resulting counts on the donor and acceptor channels, *n*^Cy3^ and *n*^Cy5^, were used to calculate an apparent FRET efficiency $\documentclass[12pt]{minimal}
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}{}${E_{app}}$\end{document}$ = (*n*^Cy5^ -- χ*n*^Cy3^) / (*n*^Cy5^ -- χ*n*^Cy3^ + *n*^Cy3^) for each EF-Tu molecule. Here, the bleed-through parameter, χ, was estimated using molecules with only a donor label. The data were not corrected for differential detector sensitivity or quantum yields, so FRET values should be interpreted as reporting on relative distances. Histograms representing the distribution of FRET efficiencies for individual EF-Tu molecules reveal different populations of conformations. The histograms were fitted by the sum of three beta distributions by maximum likelihood estimation with the software application MEMLET ([@B31]). Uncertainties of each fit parameter were estimated via boot-strapping (see Supplement). For each component beta distribution, we report the average apparent FRET efficiency, *E*~App~, total counts for each population, A, and beta component widths, *w* along with their 95% confidence intervals \[C.I.\] ([Supplementary Table S1](#sup1){ref-type="supplementary-material"}). The standard errors, δ, reported in the text, are defined as the span of the 95% confidence interval divided by four. Equations for the beta distribution, *E*~App~, and *w* are given in the Supplement. One of these sub-populations, with a transfer efficiency near zero (Figure [3](#F3){ref-type="fig"}), is a robust artefact resulting from molecules without the acceptor dye or with a bleached acceptor dye. We identify the remaining two subpopulations as distinct conformational states of EF-Tu.

RESULTS {#SEC3}
=======

Overall structure of *E. coli* EF-Tu·GDPNP {#SEC3-1}
------------------------------------------

Full length *E. coli* EF-Tu (residues 1--393) was purified and crystallized in complex with GDPNP. X-ray diffraction data were collected to 2.5 Å resolution (Table [1](#tbl1){ref-type="table"}). The crystals belong to the space group *P*2~1~2~1~2 with the unit cell parameters *a* = 61.24 Å, *b* = 243.59 Å and *c* = 67.13 Å. The structure was determined by molecular replacement using coordinates extracted from the *E. coli* EF-Tu·GDP structure (PDB: 1EFC; ([@B10])) as the search model.

###### 

Data collection and refinement statistics. Statistics for the highest-resolution shell are shown in parentheses

                                   *E. coli* EF-Tu·GDPNP
  -------------------------------- --------------------------
  Wavelength (Å)                   1.0379
  Resolution range (Å)             29.43--2.47 (2.56--2.47)
  Space group                      *P* 21 21 2
  Unit cell (Å)                    61.24 243.60 67.13
  Total reflections                283 684 (24 406)
  Unique reflections               36 491 (3509)
  Multiplicity                     7.8 (7.0)
  Completeness (%)                 98.29 (95.64)
  Mean *I*/sigma(*I*)              18.1 (4.2)
  Wilson *B*-factor                34.03
  *R*-merge                        10.4 (76.3)
  CC1/2                            99.6 (79.9)
  Reflections used in refinement   36 409 (3468)
  Reflections used for R-free      2068 (196)
  *R*-work                         0.1708 (0.2892)
  *R*-free                         0.2099 (0.3192)
  Number of non-hydrogen atoms     6341
  Macromolecules                   5942
  Ligands                          149
  Solvent                          250
  Protein residues                 772
  RMS(bonds) (Å)                   0.003
  RMS(angles) (°)                  0.61
  Ramachandran favored (%)         97.66
  Ramachandran outliers (%)        0.00
  Average B-factor                 40.12
  Macromolecules                   39.97
  Ligands                          44.46
  Solvent                          41.28

The crystal unit cells contained two copies of EF-Tu·GDPNP, two Mg^2+^ ions and 362 water molecules. Both protein chains were unambiguously traced in the electron density from Thr8 to Ser393. Structure statistics for the model of *E. coli* EF-Tu·GDPNP are provided in Table [1](#tbl1){ref-type="table"}.

Each chain of EF-Tu·GDPNP in the final model consists of three domains (Figure [1](#F1){ref-type="fig"}) in agreement with previously determined structures. The three domains have a mutual orientation resembling the open, GDP-bound conformation of other known EF-Tu structures ([@B8],[@B15]) despite unambiguous electron density for the γ-phosphate of the GDPNP molecule (Figure [2B](#F2){ref-type="fig"}).

![The open structure of EF-Tu·GDPNP. The cartoon representation is colour coded as follows: Domain I (residues 1--200) is cyan except for the Switch 1 region (red), the switch 2 region (orange), and the *P*-loop (yellow). Domain II (residues 201--300) is coloured light blue and Domain III (residues 301--393) is dark blue. GDPNP is shown as magenta sticks. In the upper right corner, the closed conformation of EF-Tu (PDB: 1OB2) is shown for comparison. The G domains are shown in the same orientation for the two conformations.](gky697fig1){#F1}

![Details of GDPNP binding. (**A**) Superpositioning of *E. coli* EF-Tu·GDPNP and *E. coli* EF-Tu·GDP (PDB:1EFC). EF-Tu·GDPNP is shown in cartoon format and residues of the *P*-loop and switch 2 regions are shown as lines. The colour coding is the same as in Figure [1](#F1){ref-type="fig"}. Water molecules are shown as red spheres, and the Mg^2+^ ion as a green sphere. For EF-Tu·GDP, residues of the P-loop and switch I and II are shown as light blue lines, while water molecules and Mg^2+^ are shown as grey spheres. (**B**) Omit map density for GDPNP. The Fo-Fc omit map density was contoured at 0.319 e^-^/Å^3^ corresponding to 3.0σ with a cushion of 4 Å. (**C**) Details of GDPNP binding. The hydrogen bonds (distance: \<3.2 Å) between GDPNP and EF-Tu as well as the coordination of Mg^2+^ by GDPNP and EF-Tu are indicated by light blue lines. Interactions involving water molecules are not shown.](gky697fig2){#F2}

The space group and the unit cell parameters are essentially identical to those of *E. coli* EF-Tu·GDP determined by Song *et al.* ([@B10]). The overall conformation is likewise nearly identical. Superimposing the *E. coli* EF-Tu·GDPNP and EF-Tu·GDP (PDB:1EFC) structures yields a root-mean-square deviation (rmsd) of 0.200 Å (Figure [2A](#F2){ref-type="fig"}).

Guanine-nucleotide binding and structure of the switch regions of EF-Tu·GDPNP {#SEC3-2}
-----------------------------------------------------------------------------

Overall, the GDP part of GDPNP is bound as in the previously reported structures of EF-Tu·GDP ([@B8],[@B15]) via a network of hydrogen bonds involving amino acids located in four loop regions connecting β-strands with α-helices (Figure [2C](#F2){ref-type="fig"}). In short, the binding of the guanine moiety is mediated by hydrogen bonds to the amino acid residues Asn135, Asp138, Ser173, Ala174 and Leu175 and the aliphatic part of the Lys136 side chain stacks with the guanine ring. The ribose interacts with the amino group of Lys136 and through a water molecule with Thr26. The α-phosphate interacts with Thr26 and a water molecule, which in turn is coordinating the Mg^2+^ ion. The oxygens of the β-phosphate interact with amides of the P-loop (residues 18--25), the side chain of Thr25, and the amino group of Lys24. One of the β-phosphate oxygens chelates the Mg^2+^ ion. The only difference in coordination of the Mg^2+^ ion is the replacement of a water molecule in the GDP-structure with a γ-oxygen of GDPNP in the present structure. Positions of water molecules coordinating the Mg^2+^ ion are maintained as compared to the GDP structure, while other waters observed near the phosphate binding loop are either absent or have shifted position.

The β,γ-imido group of GDPNP interacts with the carboxylate group of Asp21 as previously observed in EF-Tu·GDPNP structures. The presence of the additional phosphate group causes only minor changes in the structure around the binding site; the side chain of Val20 rotates 120° around chi1, the carbonyl oxygen of Pro82 moves 1.2 Å and this movement propagates as an overall small movement of Cα atoms in the entire switch II region of ∼0.5 Å (Figure [2A](#F2){ref-type="fig"}). The rotation of Val20 and the interaction of the β,γ-imido group with Asp21 is also seen in structures of EF-Tu in complex with GDPNP in the closed form e.g. in EF-Tu·GDPNP·Phe-tRNA^Phe^·kirromycin (PDB: 1OB2). In contrast, the interactions observed in the structures of *T. aquaticus* EF-Tu·GDPNP ([@B17]) and *T. thermophilus* EF-Tu·GDPNP ([@B16]) between the γ-phosphate oxygens and the main chain at residues Gly83 and Thr62 as well as the side chain of Thr62 are not present in our structure of *E. coli* EF-Tu·GDPNP.

Dynamics of freely diffusing EF-Tu analysed by fluorescence burst detection microscopy {#SEC3-3}
--------------------------------------------------------------------------------------

The surprising finding that *E. coli* EF-Tu bound to GDPNP displays the open structure known from the GDP-bound form of the factor was complemented by a study of the dynamic distribution of *E. coli* EF-Tu conformations in solution using a FRET approach. FRET requires the covalent attachment of fluorescent donor and acceptor fluorophores at positions expected to efficiently report on structural changes. Commonly, the covalent attachment of fluorescent probes occurs via native or engineered cysteine residues ([@B32]).

Previously, we have prepared a mutant of *E. coli* EF-Tu, denoted EF-Tu^AV^, in which the native cysteines at positions 137 and 255 were replaced by alanine and valine, respectively, while the cysteine at position 81 was retained to avoid loss of activity ([@B33]). In the EF-Tu^AV^ background, pairs of cysteines were introduced at either positions 33 and 351, positions 47 and 314 or positions 165 and 314 to report on relative distance changes between domains I and III after labeling with the FRET reporter pair Cy3 and Cy5 ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"}). The resulting mutants were named EF-Tu^AV-33/351^, EF-Tu^AV-47/314^ and EF-Tu^AV-165/314^, respectively. Single-molecule total internal reflection fluorescence (TIRF) microscopy of dual-labeled EF-Tu^AV-33/351^ allowed the detection of a structural transition of EF-Tu on the ribosome, which was dependent on GTP hydrolysis. In contrast, the dual-labeled mutants EF-Tu^AV-47/314^ and EF-Tu^AV-165/314^ reported little or no distance change ([@B28]).

Here, dual-labeled EF-Tu^AV-33/351^ is subject to a detailed, fluorescence burst detection microscopy analysis to monitor the structural distribution free in solution ([@B29],[@B30]), while dual-labeled EF-Tu^AV-47/314^ and EF-Tu^AV-165/314^ are described in less detail because their distance changes were so small.

All mutants were simultaneously labeled with Cy3 and Cy5 maleimides to give a mixture of EF-Tu labeled with both Cy3 and Cy5 (dual-labeled EF-Tu) as well as EF-Tu labeled with Cy3 or Cy5 only. Nearly equal incorporation of Cy3 and Cy5 was observed. Under the applied labeling conditions, the background labeling of Cys81 was ∼0.1 dye/protein, while the total labeling of EF-Tu^AV-33/351^, EF-Tu^AV-47/314^ and EF-Tu^AV-165/314^ were 1.0--1.2 dye/protein (data not shown). In the accompanying study, the three labeled EF-Tu mutants were found to have activities comparable to wild-type EF-Tu with respect to poly(Phe) synthesis, protection of the ester bond of Phe-tRNA^Phe^ from spontaneous hydrolysis, and accommodation of Phe-tRNA^Phe^ into the ribosomal A site ([@B28]). The expected distances between the labels in the GDP- and GTP-bound forms (based on PDB entries 1DG1 and 1OB2, respectively) as well as the corresponding theoretical FRET values are given in [Supplementary Figure S1](#sup1){ref-type="supplementary-material"}. The calculation is based on *R*~o~ = 5.0 nm and the assumption that κ^2^ = 2/3, which is common for relative distance measurements ([@B34]).

Fluorescence burst detection of freely diffusing complexes was applied to measure FRET values of dual-labeled EF-Tu^AV-33/351^ both free and bound to the ribosome (Figure [3](#F3){ref-type="fig"} and [Supplementary Table S1](#sup1){ref-type="supplementary-material"}). Distributions of apparent FRET values, *E*~App~, in Figures [3A](#F3){ref-type="fig"}--[H](#F3){ref-type="fig"} were fitted by a mixture of three beta distributions, showing a peak at the zero position due to EF-Tu molecules containing only Cy3 labels or bleached Cy5, and two non-zero peaks. The higher peak has an essentially constant *E*~App~ around 0.97 (*E*~App3~, [Supplementary Table S1](#sup1){ref-type="supplementary-material"}), while the *E*~App2~ value and width (*w*~2~) of the middle peak display significant differences, depending on the EF-Tu complex ([Supplementary Tables S1 and S2](#sup1){ref-type="supplementary-material"}). The higher *E*~App~ peak is not due to direct excitation of Cy5, since an EF-Tu mutant labeled site-specifically with Cy5 at position 159 (Figure [3I](#F3){ref-type="fig"}) displayed only the peak at zero FRET due to cross-talk between the excitation and detection channels. Thus, the non-zero peaks represent dual-labeled EF-Tu molecules belonging to populations with different FRET efficiencies.

![FRET distributions of dual-labeled EF-Tu^AV-33/351^ on and off the ribosome. Dual-labeled EF-Tu^AV-33/351^ was observed for 10 min under a confocal microscope at 50 pM concentration to detect fluorescence bursts under different conditions: (**A**) 1 mM GDP; (**B**) 1 mM GTP, 3 mM PEP, 0.005 mg/ml pyruvate kinase; (**C**) 2 μM Phe-tRNA^Phe^, 1 mM GTP, 3 mM PEP, 0.005 mg/ml pyruvate kinase; (**D**) 1 mM GTP, 3 mM PEP, 0.005 mg/ml pyruvate kinase, 30 μM kirromycin; (**E**) 1 mM GDPNP; (**F**) 2 μM Phe-tRNA^Phe^, 500 pM 70SIC, 1 mM GTP, 3 mM PEP, 0.005 mg/ml pyruvate kinase, 30 μM kirromycin; (**G**) pellet of EF-Tu^AV-33/351^·GDP·kirromycin·Phe-tRNA^Phe^·70SIC obtained after ultracentrifugation through a sucrose cushion; (**H**) supernatant from (**G**). (**I**) A negative control containing the Cy5-labeled EF-Tu mutant Q159C showed no fluorescence bursts in the high-FRET region, when illuminated with a 514-nm laser. The common peak below *E*~App~ = 0.2 is an artefact resulting from molecules with no or inactive acceptor fluorophores. Fitted apparent FRET values, *E*~App~, total counts for each population, *A*, and beta distribution widths, *w*, are provided in [Supplementary Table S1](#sup1){ref-type="supplementary-material"}. A statistical comparison of *E*~App2~ and *w*~2~ values obtained for the mid-FRET peaks under different conditions are provided in [Supplementary Table S2](#sup1){ref-type="supplementary-material"}. The *E*~App3~ values of the high FRET peaks falling in the range 0.95--0.97 displayed no significant differences. Individual beta function fits are shown as dashed lines, while the solid line corresponds to their sum.](gky697fig3){#F3}

In assessing the significance of the results presented in Figure [3](#F3){ref-type="fig"}, the three parameters to be considered are the mean FRET efficiency, *E*~App2~, and width, *w*~2~, of the intermediate FRET peak, as well as *f*$\documentclass[12pt]{minimal}
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}{}$ = \frac{{{A_2}}}{{{A_2} + {A_3}}}$\end{document}$, the ratio of events in the mid-FRET peak to the total number of events in the mid- and high-FRET peaks ([Supplementary Table S1](#sup1){ref-type="supplementary-material"}). The GDP-bound form of EF-Tu^AV-33/351^ has an intermediate peak corresponding to an apparent FRET efficiency of 0.78 ± 0.01 (*E*~App2~ ± δ~2~) with width 0.186 ± 0.004 (*w*~2~ ± δ*~w~*~2~), where δ~2~ and δ*~w~*~2~ are the S.E.M. uncertainties of *E*~App2~ and *w*~2~, respectively (Figure [3A](#F3){ref-type="fig"}, [Supplementary Table S1](#sup1){ref-type="supplementary-material"}). This is consistent with the expected value of 0.74 based on the structure of the EF-Tu·GDP complex ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"}; [@B8],[@B15]). In contrast, the *E*~App2~ values related to GTP-like forms of EF-Tu (0.53--0.69, Figures [3B](#F3){ref-type="fig"}--[E](#F3){ref-type="fig"}) are higher than the expected value of 0.41 based on the structures of the EF-Tu·GDPNP complex ([@B16],[@B17]), the ternary complex ([@B18]), or the aurodox (a kirromycin analogue) complex of EF-Tu·GDP ([@B35]), which is similar to EF-Tu·GTP. The central FRET peaks in the GTP-like forms (panels B-E) are also significantly wider (*w*~2~ ≥ 0.21 ± 0.01) than the GDP state (*w*~2~ = 0.186 ± 0.004) ([Supplementary Table S2](#sup1){ref-type="supplementary-material"}). These *w*~2~ values are larger than would occur due to the statistics of photon counting in the fluorescence bursts ([@B36]) suggesting variability and/or dynamics of the inter-probe distance in the GTP-like states.

The free, GTP-bound forms of EF-Tu^AV-47/314^ ([Supplementary Figures S2B and S2C](#sup1){ref-type="supplementary-material"}) and EF-Tu^AV-165/314^ ([Supplementary Figures S2G and S2H](#sup1){ref-type="supplementary-material"}) did not show a prominent wide mid-FRET peak similar to that of the free, GTP-bound species of EF-Tu^AV-33/351^ (Figures [3B](#F3){ref-type="fig"}--[E](#F3){ref-type="fig"}). This may partly be due to the fact that the predicted FRET differences between the structural extremes of EF-Tu^AV-47/314^ and EF-Tu^AV-165/314^ are much smaller than for EF-Tu^AV-33/351^ ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"}). No mid-FRET peak of the GDP-form of EF-Tu^AV-47/314^ ([Supplementary Figure S2A](#sup1){ref-type="supplementary-material"}) could be distinguished, possibly due to its merger with the ubiquitous high-FRET peak. For EF-Tu^AV-165/314^, the histogram of the GDP-bound complex ([Supplementary Figure S2F](#sup1){ref-type="supplementary-material"}) did reveal a small broad peak indicative of a distinct, open conformation, which is notably absent in the histograms of the GTP-bound complexes of this mutant ([Supplementary Figures S2G and H](#sup1){ref-type="supplementary-material"}).

Ribosome-binding shifts the conformational equilibrium of EF-Tu·GTP towards the active conformation {#SEC3-4}
---------------------------------------------------------------------------------------------------

Our expectation of detecting a distinct closed conformation of EF-Tu bound to small ligands was not realized, since none of the free GTP or GTP analogue forms of EF-Tu^AV-33/351^ (Figures [3B](#F3){ref-type="fig"}--[E](#F3){ref-type="fig"}) displayed the predicted *E*~App2~ value of 0.41. Likewise, EF-Tu^AV-47/314^ bound to GTP did not show a distinct peak at 0.77 ([Supplementary Figures S2B and S2C](#sup1){ref-type="supplementary-material"}), while EF-Tu^AV-165/314^ turned out to be a poor reporter of the structural changes due to the omnipresent high-FRET peak that would obscure the expected peak around 0.99.

In order to drive EF-Tu into the closed conformation known from structural studies, the ternary complexes of EF-Tu^AV-33/351^ and EF-Tu^AV-47/314^ were added to a five-fold excess of the 70S initiation complex (70SIC) in the presence of kirromycin. For EF-Tu^AV-33/351^, this caused a reduction in the *E*~app2~ value to 0.47 ± 0.01 (*w*~2~ = 0.20 ± 0.01) (Figure [3F](#F3){ref-type="fig"} and [Supplementary Table S1](#sup1){ref-type="supplementary-material"}). Isolation of ribosome-bound complexes in this sample by ultracentrifugation gave a more distinct, narrower (*w*~2~ = 0.15 ± 0.004) FRET peak with a similar *E*~app2~ of 0.45 ± 0.01 (Figure [3G](#F3){ref-type="fig"}), and a large increase in the area of the intermediate relative to higher FRET peak (*f* in [Supplementary Table S1](#sup1){ref-type="supplementary-material"}). Concomitantly, this ratio was decreased in the supernatant resulting after ultracentrifugation (Figure [3H](#F3){ref-type="fig"}), indicating that the higher FRET (*E*~app3~ ∼ 0.98) form of dual-labeled EF-Tu^AV-33/351^ is bound to the ribosome more weakly than the intermediate FRET form and may correspond to less active material. Notably, the *E*~App2~ and *w*~2~ values observed for ribosome-bound EF-Tu^AV-33/351^ are significantly different from those observed in complexes that are not ribosome-bound ([Supplementary Table S2](#sup1){ref-type="supplementary-material"}). Importantly, all of these observations are independent of both the fitting procedure employed and the instrument calibration.

For EF-Tu^AV-47/314^, 70SIC binding ([Supplementary Figure S2D](#sup1){ref-type="supplementary-material"}) cause the appearance of EF-Tu molecules with intermediate FRET efficiencies averaging lower (E~App2~ = 0.52 ± 0.03) than the predicted value of 0.77. This discrepancy may reflect a variable position of residue 47, which resides in the flexible switch I region.

DISCUSSION {#SEC4}
==========

Our X-ray crystallographic study shows that *E. coli* EF-Tu bound to GDPNP can take up an open conformation equivalent to the inactive, GDP-bound form of the factor. Single-molecule FRET studies of *E. coli* EF-Tu bound to various ligands support this finding and show that in solution, EF-Tu samples a set of conformations, which are driven towards the well-known GTP-bound conformation upon binding to the ribosome.

Accommodation of GDPNP in the open conformation of EF-Tu {#SEC4-1}
--------------------------------------------------------

The accommodation of the additional phosphate of GDPNP in the GDP conformation appears to require small movements of the switch 2 region. These movements do not propagate to the switch 1 region, as observed for *Thermus* EF-Tu·GDPNP, so that the three domains remain in the open conformation. This indicates that partitioning among the conformations differs for EF-Tu isolated from different sources. A similar observation has been made for members of the Ras-family of small GTPases, which exist in a dynamic equilibrium between an active and an inactive conformation when bound to GDPNP, as observed here for *E. coli* EF-Tu (Figure [3E](#F3){ref-type="fig"}). In ras, the conversion between the active and inactive GDPNP-bound form involves mainly the switch regions ([@B37]). Three substates have been defined for the inactive state of ras, of which substate 1 (H-Ras; PDB: 3KKN) is characterized by the dissociation of Thr35 and Gly60 from the γ-phosphate ([@B40]). This is similar to the absence of an interaction between the γ-phosphate and the equivalent Thr61 and Gly83 in the present structure. Thus, the open and closed conformations of EF-Tu·GDPNP may be analogous to the inactive and active forms of GDPNP-bound Ras p21, respectively.

It may appear puzzling why *E. coli* EF-Tu·GDPNP crystallize in the open conformation as opposed to the closed conformation observed upon crystallization of *Thermus* EF-Tu·GDPNP. A plausible explanation is that the equilibrium constant for the transition between closed and open GDPNP-bound conformations differs between EF-Tu from different species, and during crystallization different structural states are captured. For Ras isoforms ([@B41]) and members of the Ras family of GTPases ([@B42],[@B43]), the equilibrium constants governing the structural interconversion between the active and inactive GDPNP-bound states, which correspond to the closed and open forms of GDPNP-bound EF-Tu, respectively, have been shown to differ markedly, likely due to residues flanking the switch 1 region that may play a role in balancing the structural equilibrium ([@B41],[@B44]). The sequence alignment of EF-Tu from 897 different species reveals a 'hotspot' of variability (residues 37--48 in *E. coli* EF-Tu) located prior to and in the N-terminal part of the switch 1 region ([Supplementary Figure S3](#sup1){ref-type="supplementary-material"}). Moreover, the variation is particularly pronounced when comparing *E. coli* EF-Tu with EF-Tu of thermophilic origin. This diversity may, along with differences in crystallization conditions, account for the distinct states taken up by EF-Tu·GDPNP complexes of different origin upon crystallization.

In the active conformation, EF-Tu is capable of hydrolyzing GTP through activation of a water molecule by His84 ([@B45]). In the present structure, this histidine is 2.3 Å further away from the γ-phosphate than observed in the active conformation. Furthermore, we do not observe any water molecules in the structure positioned for a nucleophilic attack. Thus, it is unlikely that GTP hydrolysis occurs in the open conformation. Similarly, the two water molecules essential for intrinsic GTP hydrolysis by H-Ras were found to be absent in the inactive, GDPNP-bound state ([@B46]).

Conformational dynamics of EF-Tu in solution {#SEC4-2}
--------------------------------------------

For decades, the accepted view of the superfamily of GTPases has been that the members of this family switch between structurally distinct conformations depending on the nature of the bound nucleotide ([@B2]). In particular, X-ray crystallographic studies of EF-Tu ([@B7]) off the ribosome have defined two different conformations: the closed, active, GTP-bound form and the open, inactive, GDP-bound form. Recently, the role of conformational dynamics as a regulator of molecular recognition has been highlighted ([@B47]). In particular, the model of 'conformational selection' (or 'population shift') suggests that ligand-binding proteins exist in a dynamic equilibrium of conformations of which only a subset binds ligand. This strategy of ligand binding is opposed to the 'induced fit' strategy according to which ligand binding induces a new protein conformation, which leads to tighter binding. For EF-Tu as well as other GTPases, the rigid reaction scheme entailing switching between two structural extremes has become more flexible and dynamic ([@B5]), and our data indicate that the dynamics of EF-Tu fit better to a 'conformational selection' scheme rather than an 'induced fit' model.

Our fluorescence burst detection studies of dual-labeled EF-Tu^AV-33/351^ support the view by Ehrenberg and coworkers ([@B5]) that effector binding rather than nucleotide binding defines the conformational state of a GTPase. The EF-Tu^AV-33/351^·GDP complex in solution has an apparent FRET value (0.78 ± 0.01, Figure [3A](#F3){ref-type="fig"}) consistent with that predicted for the EF-Tu·GDP crystal structures (0.74, [Supplementary Figure S1](#sup1){ref-type="supplementary-material"}). In contrast, the EF-Tu^AV-33/351^ complexes in solution considered to be 'EF-Tu·GTP'-like, based on crystal structures (EF-Tu·GDPNP ([@B17]), EF-Tu·GDPNP·aa-tRNA ([@B18]), EF-Tu·GDP·kirromycin ([@B35])), appear to exist in a dynamic equilibrium of conformations, with apparent FRET values falling on a continuum between those expected for 'EF-Tu·GTP' and 'EF-Tu·GDP' (0.53--0.69; Figure [3B](#F3){ref-type="fig"}--[E](#F3){ref-type="fig"}), and with central FRET peaks which are significantly broader ([Supplementary Table S2](#sup1){ref-type="supplementary-material"}) than that of the GDP state. Indeed, it is only when EF-Tu^AV-33/351^ is bound to its effector, the ribosome, as a kirromycin-inhibited ternary complex, that it displays an apparent FRET value (0.47, with a narrow *w*~2~ of 0.15, Figure [3G](#F3){ref-type="fig"}) similar to the value expected from the EF-Tu·GTP crystal structure (0.41; [Supplementary Figure S1](#sup1){ref-type="supplementary-material"}). A similar tendency is observed for EF-Tu^AV-47/314^ ([Supplementary Figure S2D](#sup1){ref-type="supplementary-material"}). Other ribosome-related GTPases exhibit a similar behaviour: EF-G·GTP switches from an elongated to a compact conformation upon binding to the pretranslocation ribosome ([@B48]); the GTP-bound form of eIF5B has a higher affinity for the ribosome than the GDP-bound form ([@B49]) despite strong similarity in the structures of the free, binary complexes ([@B50]); IF2, which appears to be flexible in solution, converts into an extended, well-defined conformation on binding to the ribosome ([@B51]); and the conformation of the ribosome-bound stress-response factor BipA differs from that of isolated BipA ([@B52]). The conformational equilibrium of GTP-bound Ras-p21 is also shifted towards the active structure upon effector binding ([@B37],[@B41],[@B53]).

The modest differences within the group of conformations exhibited by the GDP- and GTP-bound forms of EF-Tu^AV-33/351^ reported by FRET (Figure [3A](#F3){ref-type="fig"} and [B](#F3){ref-type="fig"}) cannot easily explain the difference in aa-tRNA affinities of two orders of magnitude between the two binary complexes in solution ([@B56]). However, the apparently more dynamic behaviour of the GTP-bound conformation, as manifested by a higher *w*~2~ value, along with a slightly more closed conformation, as measured by *E*~App2~ reporting on the distance between positions 33 and 351, may explain the difference. Upon binding of Phe-tRNA^Phe^ to EF-Tu^AV-33/351^·GTP (Figure [3C](#F3){ref-type="fig"}), the structural equilibrium is driven further towards the closed conformation as indicated by a decrease in *E*~App2~. Notably, EF-Tu^AV-33/351^ in the ternary complex is quite dynamic (it has the same *w*~2~ as the GTP-bound complex) and the fully closed conformation is reached only upon interaction with the 70SIC (Figure [3G](#F3){ref-type="fig"}) i.e., crystallization and ribosome binding bring EF-Tu·GTP·aa-tRNA into similar low-fluctuation minima ([@B57]).

Our observation that EF-Tu adopts more GTP-like conformations on the ribosome may imply a role of EF-Tu during accommodation. Noel and Whitford ([@B58]) have shown that on the ribosome, EF-Tu in its GTP-like state reduces the number of conformations available to the transported tRNA molecule and thereby facilitates accommodation of the tRNA elbow. This is in agreement with our accompanying study of conformational dynamics of EF-Tu during aa-tRNA delivery ([@B28]), which also highlights a possible involvement of EF-Tu during the accommodation process.

CONCLUSION {#SEC5}
==========

Traditionally, the activation of G-proteins has been thought to occur *via* an induced-fit model, where the presence or absence of the γ-phosphate of GTP determines the functional state of the protein ([@B59]). Here, we challenge this view by showing that EF-Tu·GDPNP can take up an open, GDP-like conformation in crystals and in solution. In solution, EF-Tu·GTP adopts a broad spectrum of conformations, whereas EF-Tu·GDP has a more rigid, open conformation. Our data suggest that, in binding EF-Tu·GTP in an active conformation, the ribosome selects from a pool of EF-Tu conformations spanning a continuum from the open to the closed conformation.
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